Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers.
Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A.
Colen RR, et al. Among authors: zinn po.
J Immunother Cancer. 2021 Apr;9(4):e001752. doi: 10.1136/jitc-2020-001752.
J Immunother Cancer. 2021.
PMID: 33849924
Free PMC article.